| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $347.9M | +17.0% |
| SG&A Expense | $131.1M | +6.4% |
| Operating Income | -$479.0M | -13.9% |
| Interest Expense | $2.4M | -0.9% |
| Income Tax | $0 | — |
| Net Income | -$445.1M | -8.1% |
| EPS (Basic) | -$0.96 | -1.1% |
| EPS (Diluted) | -$0.96 | -1.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $142.5M | -39.5% |
| Short-term Investments | $928.3M | +12.3% |
| Current Assets | $1.08B | +1.0% |
| Total Assets | $1.50B | +1.8% |
| Current Liabilities | $57.1M | +22.0% |
| Total Liabilities | $161.8M | +3.8% |
| Stockholders' Equity | $1.34B | +1.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$240.0M | -10.1% |
| Capital Expenditures | $84.5M | -46.8% |
| Investing Cash Flow | -$152.5M | -222.9% |
| Financing Cash Flow | $300.2M | +3391.7% |
| Free Cash Flow | -$324.5M | +13.9% |